Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients

Transplantation. 2021 Nov 1;105(11):e265-e266. doi: 10.1097/TP.0000000000003907.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • COVID-19 / epidemiology*
  • COVID-19 / immunology
  • COVID-19 / virology
  • COVID-19 Vaccines / immunology
  • Centers for Disease Control and Prevention, U.S. / statistics & numerical data
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Mass Vaccination / statistics & numerical data
  • Organ Transplantation / adverse effects*
  • Risk Assessment / statistics & numerical data
  • SARS-CoV-2 / immunology
  • Transplant Recipients / statistics & numerical data*
  • United States / epidemiology

Substances

  • COVID-19 Vaccines
  • Immunosuppressive Agents

Supplementary concepts

  • COVID-19 breakthrough infections